Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312063200 on March 19, 2004

J. Biol. Chem., Vol. 279, Issue 22, 23719-23727, May 28, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/22/23719    most recent
M312063200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, D. J.
Right arrow Articles by Peters, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D. J.
Right arrow Articles by Peters, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Peroxisome Proliferator-activated Receptor {beta} ({delta})-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin Carcinogenesis*

Dae J. Kim{ddagger}§, Taro E. Akiyama¶||, Fred S. Harman{ddagger}**, Amanda M. Burns{ddagger}, Weiwei Shan{ddagger}{ddagger}{ddagger}, Jerrold M. Ward§§, Mary J. Kennett{ddagger}, Frank J. Gonzalez¶, and Jeffrey M. Peters{ddagger}§**{ddagger}{ddagger}¶¶

From the {ddagger}Department of Veterinary Science and The Center for Molecular Toxicology and Carcinogenesis, the **Graduate Program in Biochemistry, Microbiology, Molecular Biology, {ddagger}{ddagger}Graduate Program in Genetics, §Graduate Program in Molecular Toxicology, The Huck Institute for Life Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802, the Laboratory of Metabolism, NCI, National Institutes of Health, Bethesda, Maryland 20892, and the §§Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702

The role of peroxisome proliferator-activated receptor-{beta} (PPAR{beta}) in the molecular regulation of skin carcinogenesis was examined. Increased caspase-3 activity associated with apoptosis was found in the skin of wild-type mice after tumor promotion with 12-O-tetradecanoylphorbol-13-acetate, and this effect was diminished in PPAR{beta}-null mice. The onset of tumor formation, tumor size, and tumor multiplicity induced from a two-stage carcinogen bioassay (7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate) were significantly enhanced in PPAR{beta}-null mice compared with wild-type mice. To begin to characterize the molecular changes underlying this PPAR{beta}-dependent phenotype, microarray analysis was performed and a number of differentially regulated gene products were identified including ubiquitin C. Subsequent promoter analysis, reporter gene assays, site-directed mutagenesis, and electrophoretic mobility shift assays provide evidence that PPAR{beta} regulates ubiquitin C expression, and that ubiquitination of proteins is influenced by PPAR{beta}. These results strongly suggest that activation of PPAR{beta}-dependent target genes provides a novel strategy to inhibit tumor promotion and carcinogenesis.


Received for publication, November 4, 2003 , and in revised form, February 27, 2004.

* This work supported by NCI, National Institutes of Health Grant R01 CA89607 (to J. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| Current address: Merck Research Laboratories, Rahway, NJ 07065.

¶¶ To whom correspondence should be addressed: Dept. of Veterinary Science and Center for Molecular Toxicology and Carcinogenesis, 226 Fenske Laboratory, The Pennsylvania State University, University Park, PA 16802. Tel.: 814-863-1387; Fax: 814-863-1696; E-mail: jmp21{at}psu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Watanabe, M. J. Smith, E. Heilig, V. Beglopoulos, R. J. Kelleher III, and J. Shen
Indirect Regulation of Presenilins in CREB-mediated Transcription
J. Biol. Chem., May 15, 2009; 284(20): 13705 - 13713.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. C. Chong, M. J. Tan, V. Philippe, S. H. Tan, C. K. Tan, C. W. Ku, Y. Y. Goh, W. Wahli, L. Michalik, and N. S. Tan
Regulation of epithelial-mesenchymal IL-1 signaling by PPAR{beta}/{delta} is essential for skin homeostasis and wound healing
J. Cell Biol., March 23, 2009; 184(6): 817 - 831.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. T. Bility, M. K. Devlin-Durante, N. Blazanin, A. B. Glick, J. M. Ward, B. H. Kang, M. J. Kennett, F. J. Gonzalez, and J. M. Peters
Ligand activation of peroxisome proliferator-activated receptor {beta}/{delta} (PPAR{beta}/{delta}) inhibits chemically induced skin tumorigenesis
Carcinogenesis, December 1, 2008; 29(12): 2406 - 2414.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. G. Borland, J. E. Foreman, E. E. Girroir, R. Zolfaghari, A. K. Sharma, S. Amin, F. J. Gonzalez, A. C. Ross, and J. M. Peters
Ligand Activation of Peroxisome Proliferator-Activated Receptor-{beta}/{delta} Inhibits Cell Proliferation in Human HaCaT Keratinocytes
Mol. Pharmacol., November 1, 2008; 74(5): 1429 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Shan, P. S. Palkar, I. A. Murray, E. I. McDevitt, M. J. Kennett, B. H. Kang, H. C. Isom, G. H. Perdew, F. J. Gonzalez, and J. M. Peters
Ligand Activation of Peroxisome Proliferator-Activated Receptor {beta}/{delta} (PPAR{beta}/{delta}) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression
Toxicol. Sci., October 1, 2008; 105(2): 418 - 428.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-K. Han, H.-S. Lee, H.-M. Yang, J. Hur, S.-I. Jun, J.-Y. Kim, C.-H. Cho, G.-Y. Koh, J. M. Peters, K.-W. Park, et al.
Peroxisome Proliferator-Activated Receptor-{delta} Agonist Enhances Vasculogenesis by Regulating Endothelial Progenitor Cells Through Genomic and Nongenomic Activations of the Phosphatidylinositol 3-Kinase/Akt Pathway
Circulation, September 2, 2008; 118(10): 1021 - 1033.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. E. Hollingshead, M. G. Borland, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters
Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms
Carcinogenesis, January 1, 2008; 29(1): 169 - 176.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. E. Hollingshead, R. L. Killins, M. G. Borland, E. E. Girroir, A. N. Billin, T. M. Willson, A. K. Sharma, S. Amin, F. J. Gonzalez, and J. M. Peters
Peroxisome proliferator-activated receptor- /{delta} (PPAR /{delta}) ligands do not potentiate growth of human cancer cell lines
Carcinogenesis, December 1, 2007; 28(12): 2641 - 2649.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. J Leaver, M T. Ezaz, S. Fontagne, D. R Tocher, E. Boukouvala, and G. Krey
Multiple peroxisome proliferator-activated receptor {beta} subtypes from Atlantic salmon (Salmo salar)
J. Mol. Endocrinol., March 1, 2007; 38(3): 391 - 400.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. J. Kim, K.S. Prabhu, F. J. Gonzalez, and J. M. Peters
Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta})
Carcinogenesis, May 1, 2006; 27(5): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. E. Marin, M. A. Peraza, A. N. Billin, T. M. Willson, J. M. Ward, M. J. Kennett, F. J. Gonzalez, and J. M. Peters
Ligand Activation of Peroxisome Proliferator-Activated Receptor {beta} Inhibits Colon Carcinogenesis.
Cancer Res., April 15, 2006; 66(8): 4394 - 4401.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. A. Peraza, A. D. Burdick, H. E. Marin, F. J. Gonzalez, and J. M. Peters
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Toxicol. Sci., April 1, 2006; 90(2): 269 - 295.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Kim, I. A. Murray, A. M. Burns, F. J. Gonzalez, G. H. Perdew, and J. M. Peters
Peroxisome Proliferator-activated Receptor-{beta}/{delta} Inhibits Epidermal Cell Proliferation by Down-regulation of Kinase Activity
J. Biol. Chem., March 11, 2005; 280(10): 9519 - 9527.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. T. Bility, J. T. Thompson, R. H. McKee, R. M. David, J. H. Butala, J. P. Vanden Heuvel, and J. M. Peters
Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters
Toxicol. Sci., November 1, 2004; 82(1): 170 - 182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement